Kohli Prashant 4
4 · Acasti Pharma Inc. · Filed Dec 20, 2023
Insider Transaction Report
Form 4
Kohli Prashant
DirectorChief Executive Officer
Transactions
- Award
Stock Options (Right to Buy)
2023-12-19+41,668→ 41,668 totalExercise: $2.13Exp: 2033-12-19→ Class A Common Shares (41,668 underlying)
Footnotes (1)
- [F1]Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which fully vested upon grant.